⌘K

Login Start Free

Home/Filings/4/0001572426-16-000226

4//SEC Filing

Nexvet Biopharma plc 4

Accession 0001572426-16-000226

CIK 0001618561operating

View on SEC.gov Company Profile

Filed

Sep 6, 8:00 PM ET

Accepted

Sep 7, 5:44 PM ET

Size

5.5 KB

Accession

0001572426-16-000226

Insider Transaction Report

Form 4

Period: 2016-09-05

Nexvet Biopharma plcNVET

Director

Transactions

Exercise/Conversion
Restricted Share Units
2016-09-05+3,600→ 3,600 total
Exercise: $0.13From: 2017-07-01Exp: 2021-07-01→ Ordinary Shares (3,600 underlying)

Footnotes (1)

[F1]3,600 of the Restricted Share Units shall vest and become convertible on 7/1/17, subject to payment of the nominal value per share to Issuer within 30 days of vesting.

Documents

1 file

4
edgar.xmlPrimary
PRIMARY DOCUMENT

Issuer

Nexvet Biopharma plc

CIK 0001618561

Entity typeoperating

IncorporatedIreland

Related Parties

1

filerCIK 0001618561

Filing Metadata

Form type: 4
Filed: Sep 6, 8:00 PM ET
Accepted: Sep 7, 5:44 PM ET
Size: 5.5 KB

View on SEC.gov